相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
Elke Jordan et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Aging in COVID-19: Vulnerability, immunity and intervention
Yiyin Chen et al.
AGEING RESEARCH REVIEWS (2021)
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
NATURE MEDICINE (2021)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett et al.
NATURE MEDICINE (2021)
T Cells: Warriors of SARS-CoV-2 Infection
Paola de Candia et al.
TRENDS IN IMMUNOLOGY (2021)
Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Daily briefing: The first billion COVID vaccinations
Flora Graham
NATURE (2021)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas et al.
ECLINICALMEDICINE (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Current challenges: from the path of original antigenic sin towards the development of universal flu vaccines
Asim Biswas et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?
Asim Biswas et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2020)
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
Hao Cheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs
Michele M. Ciulla
HYPERTENSION RESEARCH (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design
Dongliang Wang et al.
VACCINES (2020)
COVID-19, Virology and Geroscience: A Perspective
C. Vellas et al.
JOURNAL OF NUTRITION HEALTH & AGING (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
A thermostable, closed SARS-CoV-2 spike protein trimer
Xiaoli Xiong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
MAKING SENSE OF CORONAVIRUS MUTATIONS
Ewen Callaway
NATURE (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Bethany Dearlove et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets
Justina Kulikauskaite et al.
TRENDS IN IMMUNOLOGY (2020)
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Yun-yu Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool
German Todorov et al.
BIOMOLECULES (2020)
SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
Sayantan Laha et al.
INFECTION GENETICS AND EVOLUTION (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Per Nived et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Airway macrophages as the guardians of tissue repair in the lung
Franz Puttur et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Immunosenescence and human vaccine immune responses
Stephen N. Crooke et al.
IMMUNITY & AGEING (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Metabolic Alterations in Aging Macrophages: Ingredients for Inflammaging?
Adriaan A. van Beek et al.
TRENDS IN IMMUNOLOGY (2019)
Models of immune selection for multi-locus antigenic diversity of pathogens
Maria Georgieva et al.
NATURE REVIEWS IMMUNOLOGY (2019)
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Thymic involution and rising disease incidence with age
Sam Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Vaccination in the elderly: The challenge of immune changes with aging
Annalisa Ciabattini et al.
SEMINARS IN IMMUNOLOGY (2018)
Age is the work of art? Impact of neutrophil and organism age on neutrophil extracellular trap formation
Weronika Ortmann et al.
CELL AND TISSUE RESEARCH (2018)
The twilight of immunity: emerging concepts in aging of the immune system
Janko Nikolich-Zugich
NATURE IMMUNOLOGY (2018)
The Cytokine TGF-β Promotes the Development and Homeostasis of Alveolar Macrophages
Xueyang Yu et al.
IMMUNITY (2017)
Aging-related Atg5 defect impairs neutrophil extracellular traps formation
Fengying Xu et al.
IMMUNOLOGY (2017)
Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice
Christine K. Wong et al.
JOURNAL OF IMMUNOLOGY (2017)
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
Motoi Suzuki et al.
LANCET INFECTIOUS DISEASES (2017)
Induction of Apoptosis and Subsequent Phagocytosis of Virus-Infected Cells As an Antiviral Mechanism
Firzan Nainu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
Giuseppe Del Giudice et al.
NPJ AGING AND MECHANISMS OF DISEASE (2017)
Influence of ageing on the microarchitecture of the spleen and lymph nodes
Vivian M. Turner et al.
BIOGERONTOLOGY (2017)
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Anna M. M. van Deursen et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older
Hector S. Izurieta et al.
CLINICAL INFECTIOUS DISEASES (2017)
The ageing human B cell repertoire: a failure of selection?
D. K. Dunn-Walters
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant
Wilbur H. Chen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults
Myron J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
mRNA vaccine delivery using lipid nanoparticles
Andreas M. Reichmuth et al.
THERAPEUTIC DELIVERY (2016)
Cellular Senescence and Lung Function during Aging Yin and Yang
Judith Campisi
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Aging of the Immune System Mechanisms and Therapeutic Targets
Cornelia M. Weyand et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Naive T Cell Maintenance and Function in Human Aging
Joerg J. Goronzy et al.
JOURNAL OF IMMUNOLOGY (2015)
The Impact of Immunosenescence on Pulmonary Disease
Michelle A. Murray et al.
MEDIATORS OF INFLAMMATION (2015)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
Zhongfang Wang et al.
NATURE COMMUNICATIONS (2015)
Immunosenescence: influenza vaccination and the elderly
Kamran Haq et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents
Jennie Johnstone et al.
PLOS ONE (2014)
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Arwen F. Altenburg et al.
VIRUSES-BASEL (2014)
Alveolar macrophages: plasticity in a tissue-specific context
Tracy Hussell et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Matrix-M (TM) adjuvant: enhancing immune responses by 'setting the stage' for the antigen
Karin Lovgren Bengtsson et al.
EXPERT REVIEW OF VACCINES (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
Samuele Calabro et al.
VACCINE (2013)
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
Sofia E. Magnusson et al.
VACCINE (2013)
A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing
Fadi Saade et al.
VACCINE (2013)
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice
Florian Krammer et al.
JOURNAL OF VIROLOGY (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine
Gaston De Serres et al.
PLOS ONE (2012)
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
Richard D. Antrobus et al.
PLOS ONE (2012)
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Yoshikazu Honda-Okubo et al.
VACCINE (2012)
The Polyfunctionality of Human Memory CD8+ T Cells Elicited by Acute and Chronic Virus Infections Is Not Influenced by Age
Alina Lelic et al.
PLOS PATHOGENS (2012)
Expanding roles for CD4+ T cells in immunity to viruses
Susan L. Swain et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Influenza virosomes as a vaccine adjuvant and carrier system
Christian Moser et al.
EXPERT REVIEW OF VACCINES (2011)
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
Karl G. Nicholson et al.
LANCET INFECTIOUS DISEASES (2011)
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu et al.
VACCINE (2011)
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation
Karen E. Dolter et al.
VACCINE (2011)
Activation of B cells by antigens on follicular dendritic cells
Mohey Eldin M. El Shikh et al.
TRENDS IN IMMUNOLOGY (2010)
B-cell diversity decreases in old age and is correlated with poor health status
Kate L. Gibson et al.
AGING CELL (2009)
Secondary Lymphoid Organs: Responding to Genetic and Environmental Cues in Ontogeny and the Immune Response
Nancy H. Ruddle et al.
JOURNAL OF IMMUNOLOGY (2009)
Eleven years of Inflexal® V-a virosomal adjuvanted influenza vaccine
Christian Herzog et al.
VACCINE (2009)
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
M. J. Levin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A critical function for CD200 in lung immune homeostasis and the severity of influenza infection
Robert J. Snelgrove et al.
NATURE IMMUNOLOGY (2008)
Accumulation of memory T cells from childhood to old age:: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment
P Saule et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
T Jefferson et al.
LANCET (2005)
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
E Mortola et al.
FEBS LETTERS (2004)
Recombinant hepatitis B vaccine (Engerix-B (R)) - A review of its immunogenicity and protective efficacy against hepatitis B
GM Keating et al.
DRUGS (2003)
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix®) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults
RW Joines et al.
VACCINE (2001)
Virus clearance through apoptosis-dependent phagocytosis of influenza a virus-infected cells by macrophages
I Fujimoto et al.
JOURNAL OF VIROLOGY (2000)
Effect of age on human neutrophil function
C Wenisch et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
分享论文
